1204017

Aldeyra Therapeutics, Inc. — FEI 3013989915

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
April 28, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Lexington, MA (United States)

Additional Details

Sponsor, Contract Research Organization

Citations

IDCFRDescription
748221 CFR 312.50General responsibilities of sponsors